AU743647B2 - Methods and reagents for decreasing allergic reactions - Google Patents

Methods and reagents for decreasing allergic reactions Download PDF

Info

Publication number
AU743647B2
AU743647B2 AU23505/99A AU2350599A AU743647B2 AU 743647 B2 AU743647 B2 AU 743647B2 AU 23505/99 A AU23505/99 A AU 23505/99A AU 2350599 A AU2350599 A AU 2350599A AU 743647 B2 AU743647 B2 AU 743647B2
Authority
AU
Australia
Prior art keywords
arg
gin
leu
ser
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU23505/99A
Other languages
English (en)
Other versions
AU2350599A (en
Inventor
Gary A. Bannon
A. Wesley Burks Jr.
Hugh A. Sampson
Howard Sosin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Seer Pharmaceuticals LLC
University of Arkansas at Fayetteville
Original Assignee
Mount Sinai School of Medicine
University of Arkansas at Fayetteville
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine, University of Arkansas at Fayetteville filed Critical Mount Sinai School of Medicine
Publication of AU2350599A publication Critical patent/AU2350599A/en
Assigned to SOSIN, HOWARD, MT. SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, UNIVERSITY OF ARKANSAS, THE reassignment SOSIN, HOWARD Amend patent request/document other than specification (104) Assignors: MT. SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK, SOSIN, HOWARD, UNIVERSITY OF ARKANSAS, THE
Application granted granted Critical
Publication of AU743647B2 publication Critical patent/AU743647B2/en
Assigned to MT. SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, PANACEA PHARMACEUTICALS, LLC, UNIVERSITY OF ARKANSAS, THE reassignment MT. SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY Alteration of Name(s) of Applicant(s) under S113 Assignors: MT. SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, SOSIN, HOWARD, UNIVERSITY OF ARKANSAS, THE
Assigned to SEER PHARMACEUTICALS, LLC, MT. SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, UNIVERSITY OF ARKANSAS, THE reassignment SEER PHARMACEUTICALS, LLC Request to Amend Deed and Register Assignors: MT. SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, PANACEA PHARMACEUTICALS, LLC, UNIVERSITY OF ARKANSAS, THE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU23505/99A 1998-01-31 1999-01-29 Methods and reagents for decreasing allergic reactions Ceased AU743647B2 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US7328398P 1998-01-31 1998-01-31
US60/073283 1998-01-31
US7463398P 1998-02-13 1998-02-13
US7459098P 1998-02-13 1998-02-13
US7462498P 1998-02-13 1998-02-13
US60/074633 1998-02-13
US60/074624 1998-02-13
US60/074590 1998-02-13
US14122098A 1998-08-27 1998-08-27
US09/141220 1998-08-27
PCT/US1999/002031 WO1999038978A1 (en) 1998-01-31 1999-01-29 Methods and reagents for decreasing allergic reactions

Publications (2)

Publication Number Publication Date
AU2350599A AU2350599A (en) 1999-08-16
AU743647B2 true AU743647B2 (en) 2002-01-31

Family

ID=27535962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23505/99A Ceased AU743647B2 (en) 1998-01-31 1999-01-29 Methods and reagents for decreasing allergic reactions

Country Status (8)

Country Link
US (1) US7485708B2 (OSRAM)
EP (1) EP1051494B1 (OSRAM)
JP (1) JP2002501748A (OSRAM)
AT (1) ATE430199T1 (OSRAM)
AU (1) AU743647B2 (OSRAM)
CA (1) CA2319437C (OSRAM)
DE (1) DE69940805D1 (OSRAM)
WO (1) WO1999038978A1 (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE430199T1 (de) 1998-01-31 2009-05-15 Univ Arkansas Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
ATE408690T1 (de) * 1998-03-16 2008-10-15 Alk Abello As Mutiertes rekombinantes allergen
US6686164B1 (en) 1998-10-30 2004-02-03 Novozymes A/S Low allergenic protein variants
JP2003500003A (ja) * 1998-10-30 2003-01-07 ノボザイムス アクティーゼルスカブ 低いアレルゲン性のタンパク質変異型
US20020009452A1 (en) * 1999-02-10 2002-01-24 Michael Caplan Method for altering undesirable immune responses to polypeptides
WO2000052154A2 (en) * 1999-03-02 2000-09-08 The Board Of Trustees Of The University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
WO2000051647A2 (en) * 1999-03-03 2000-09-08 Mount Sinai School Of Medicine Of New York University Animal model of allergies
AU1921601A (en) * 1999-11-19 2001-05-30 Alabama A & M University Down-regulation and silencing of allergen genes in transgenic peanut seeds
US6943010B1 (en) 1999-11-19 2005-09-13 Hortense W. Dodo Down-regulation and silencing of allergen genes in transgenic peanut seeds
AU2065801A (en) * 1999-12-06 2001-06-12 Panacea Pharmaceuticals, Llc Passive desensitization
WO2001031989A2 (en) * 1999-12-09 2001-05-10 Novozymes A/S High throughput screening (hts) assays for protein variants with reduced antibody binding capacity
AU2631501A (en) 2000-01-06 2001-07-16 Monsanto Technology Llc Preparation of deallergenized proteins and permuteins
GB0006437D0 (en) * 2000-03-17 2000-05-10 Leuven Res & Dev Vzw Compounds for the modulation of allergen sensitivity by antigens sharing T cell epitopes with allergens
EP1272213B1 (en) * 2000-04-06 2006-03-08 SEER Pharmaceuticals, LLC. Microbial delivery system
CA2406621A1 (en) * 2000-04-28 2001-11-08 Novozymes A/S Protein variants having modified immunogenicity
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
KR100919914B1 (ko) * 2000-11-16 2009-10-06 알크-아벨로 에이/에스 신규한 돌연변이체 알레르겐
AU2002306850A1 (en) * 2001-03-16 2002-10-03 Panacea Pharmaceuticals Methods and reagents for decreasing clinical reaction to allergy
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
DE60205907T2 (de) 2002-09-27 2006-02-16 Biomay Produktions- Und Handels-Aktiengesellschaft Hypoallergene Impfstoffe gegen Allergie basierend auf Lieschgraspollenallergen Phl p 7
WO2005121166A1 (en) * 2004-06-10 2005-12-22 Monash University Novel immunointeractive molecules and uses thereof
AU2005252268B2 (en) * 2004-06-10 2012-06-28 Aravax Pty Limited Novel immunointeractive molecules and uses thereof
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
EP2243791A1 (en) 2009-03-03 2010-10-27 PLS-Design GmbH Cloning and recombinant production of Vespula venom protease and methods of use thereof
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
EP2664624A1 (en) 2012-05-15 2013-11-20 Biomay Ag Allergen variants
JP6608282B2 (ja) 2012-10-30 2019-11-20 アラヴァックス ピーティーワイ リミテッド 新規免疫療法用分子およびその使用
KR102233251B1 (ko) 2013-04-03 2021-03-26 엔-폴드 엘엘씨 신규 나노입자 조성물
RU2689552C2 (ru) 2013-09-25 2019-05-28 Аравакс Пти Лтд Новая иммунотерапевтическая композиция и ее применения
CN104280555B (zh) * 2014-10-24 2017-09-26 江南大学 一种快速检测花生过敏原Ara h 2的胶体金试纸条及其制备方法
US9920100B2 (en) 2015-06-05 2018-03-20 The Chinese University Of Hong Kong Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy
CN109295250B (zh) * 2018-10-31 2022-03-22 四川华汉三创生物科技有限公司 一种食源性植物过敏原成分的检测试剂盒和方法
KR102811748B1 (ko) * 2019-03-13 2025-05-26 주식회사 마크로젠 알레르기 치료를 위한 에피토프-기반 접근법 및 크론병에 대한 억제제
WO2025212530A1 (en) 2024-04-01 2025-10-09 N-Fold Llc Nanoparticle manufacturing

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US580862A (en) * 1897-04-20 Cloth computing and measuring machine
US569345A (en) * 1896-10-13 Albert p
US548972A (en) * 1895-10-29 Weed-cutter
US576149A (en) * 1897-02-02 Gustavus a
SE337223B (OSRAM) * 1967-05-23 1971-08-02 Pharmacia Ab
US3720760A (en) * 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
US4338297A (en) * 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction
US4469677A (en) * 1980-02-19 1984-09-04 Michael J Gabriel Polypeptide active immunosuppressant fraction
EP0063810B1 (en) * 1981-04-29 1986-03-05 Ciba-Geigy Ag New devices and kits for immunological analysis
US4888170A (en) 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
SE8205908D0 (sv) * 1982-10-18 1982-10-18 Pharmacia Diagnostics Ab Sett att bilda polymerskikt
US4849337A (en) * 1983-01-31 1989-07-18 Minnesota Mining And Manufacturing Company Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
CA1260828A (en) 1983-07-04 1989-09-26 Masakazu Iwai Therapeutic and prophylactic agent for gastrointestinal ulcers
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4696915A (en) * 1984-05-25 1987-09-29 Hoffmann-La Roche Inc. Parathymosin alpha
US5026545A (en) * 1984-09-17 1991-06-25 Baxter International, Inc. Treatment of allergy and composition therefor
US4658022A (en) 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
IL86583A0 (en) 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5843710A (en) * 1987-07-07 1998-12-01 Biotech Australia Pty. Limited And Csiro Vaccines against animal parasitic nematodes
US5049390A (en) * 1987-09-02 1991-09-17 Allergy Immuno Technologies, Inc. Liposome containing immunotherapy agents for treating IgE mediated allergies
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5169933A (en) * 1988-08-15 1992-12-08 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
AT393137B (de) 1988-10-14 1991-08-26 Biomay Biotech Prod Verfahren zum screenen einer expressions-cdna- klonbank zur auffindung von polynukleotiden
US5061790A (en) 1989-07-10 1991-10-29 Molecular Diagnostics, Inc. Oxidative denaturation of protein analytes
JP2787162B2 (ja) * 1989-08-24 1998-08-13 フマキラー株式会社 精製ダニアレルゲン
US5328991A (en) * 1989-11-03 1994-07-12 Immulogic Pharmaceutical Corp. Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes
ATE216401T1 (de) 1989-11-03 2002-05-15 Immulogic Pharma Corp Aus hausstaub isoliertes t-zellreaktives katzenprotein, und dessen verwendungen
US5547669A (en) * 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US5674980A (en) * 1989-12-21 1997-10-07 Biogen Inc Fusion protein comprising tat-derived transport moiety
US5804604A (en) * 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
US6897287B1 (en) * 1990-01-31 2005-05-24 Oklahoma Medical Research Foundation Ro/SSA peptide reagents for diagnosis of autoantibodies
AU7259691A (en) 1990-01-31 1991-08-21 Board Of Regents Of The University Of Oklahoma, The Assays and treatments for autoimmune diseases
US5091318A (en) * 1990-04-13 1992-02-25 Abbott Laboratories Binding of allergens to a solid phase
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
FI921524L (fi) 1990-08-08 1992-04-07 Biomay Biotech Prod Alpollenallergener och anvaendning av dessa.
DK0495064T3 (da) 1990-08-13 2001-10-15 Biomay Prod & Handel Birkepollenallergen P14 til diagnose og terapi af allergiske sygdomme
AT401180B (de) * 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
JP3139777B2 (ja) * 1990-08-27 2001-03-05 フマキラー株式会社 組換えダニアレルゲン
WO1992011859A1 (en) 1991-01-08 1992-07-23 Immulogic Pharmaceutical Corporation Peptide-mediated hyposensitization of the human t cell response to dermatophagoides spp. (house dust mite)
US5219990A (en) * 1991-01-28 1993-06-15 Biogen, Inc. Papillomavirus e2 trans-activation repressors
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US5350835A (en) * 1991-11-05 1994-09-27 Board Of Regents, University Of Texas Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
CA2117904C (en) 1992-04-13 2004-06-22 John B. Harley Methods and reagents for diagnosis of autoantibodies
US5719064A (en) 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
WO1994010194A2 (de) 1992-10-27 1994-05-11 Biomay Produktions- Und Handelsgesellschaft M.B.H. MOLEKÜLFRAGMENTE (PEPTIDE) DER HAUPTALLERGENE DER POLLEN VON BÄUMEN DER ORDNUNG $i(FAGALES)
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
SG52402A1 (en) * 1992-12-22 1998-09-28 Univ Cincinnati Oral administration of immunologically active biomolecules and other therapeutic proteins
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
DE69333985T2 (de) * 1992-12-31 2006-11-23 Immulogic Pharmaceutical Corp., Waltham Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung
EP0684812B1 (en) 1993-02-12 1998-01-21 Mayo Foundation For Medical Education And Research Condensed-phase microparticle composition and method
JP3451572B2 (ja) 1993-03-04 2003-09-29 アサヒビール株式会社 改変したダニ主要アレルゲン及びその製造方法
EP0688338A1 (en) 1993-03-12 1995-12-27 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US5710126A (en) * 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US6849427B1 (en) 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
AT401937B (de) 1993-04-01 1996-12-27 Biomay Prod & Handel Rekombinantes lieschgras pollen allergen phl p ii
US5830463A (en) 1993-07-07 1998-11-03 University Technology Corporation Yeast-based delivery vehicles
JP3350794B2 (ja) 1993-09-29 2002-11-25 アサヒビール株式会社 改変したダニ主要アレルゲン
JP2828391B2 (ja) 1993-10-29 1998-11-25 東燃株式会社 オリゴ糖を表面に有するリポソーム
US5449669A (en) * 1993-11-10 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services IgE-binding epitopes of a major heat-stable crustacean allergen derived from shrimp
US5731157A (en) * 1993-12-30 1998-03-24 The Procter And Gamble Company Two-site allergen immunoassay
US5820862A (en) 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
JPH07285875A (ja) 1994-04-19 1995-10-31 Mineo Hayazaki ノミアレルゲンの製造方法および該方法により製造されるノミアレルゲン
US5807746A (en) * 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
ES2229263T3 (es) 1995-03-28 2005-04-16 Asahi Breweries, Ltd. Sustancia alergena para acaridos obtenida mediante ingenieria genetica y proceso para la produccion de la misma.
US5840307A (en) * 1995-03-31 1998-11-24 Immulogic Pharmacuetical Corp. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
BE1009359A7 (fr) 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
US5820880A (en) 1995-06-07 1998-10-13 The United States Of America As Represented By The Secretary Of The Army Liposomal formulation
US5869040A (en) * 1995-06-07 1999-02-09 Biogen, Inc Gene therapy methods and compositions
DE69637147T2 (de) 1995-07-28 2008-03-06 Marie Curie Cancer Care Transportproteine und deren verwendungen
JPH11507840A (ja) 1995-12-29 1999-07-13 ユニバーシティ オブ アーカンソー ピーナッツアレルゲンおよび方法
US5955593A (en) * 1996-09-09 1999-09-21 Washington University BH3 interacting domain death agonist
US6017735A (en) 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses
BE1011033A6 (fr) 1997-03-05 1999-04-06 Univ Bruxelles Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
DE19713001A1 (de) 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
US5989814A (en) * 1997-04-01 1999-11-23 Reagents Of The University Of California Screening methods in eucaryotic cells
US5888760A (en) * 1997-04-10 1999-03-30 Dade Microscan Inc. Universal test systems and methods of use thereof for identifying multiple families of microorganisms
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
EP0877033B1 (en) 1997-05-08 2007-09-12 Amarnath Maitra A process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
US5891432A (en) * 1997-07-29 1999-04-06 The Immune Response Corporation Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
SE9703531D0 (sv) 1997-09-30 1997-09-30 Rudolf Valenta Non-anaphlactic forms of allergens and their use
US6024961A (en) 1997-11-14 2000-02-15 Washington University Recombinant avirulent immunogenic S typhi having rpos positive phenotype
CA2317724A1 (en) 1998-01-09 1999-07-15 Circassia Limited Methods and compositions for desensitisation
ATE430199T1 (de) 1998-01-31 2009-05-15 Univ Arkansas Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
US6218371B1 (en) 1998-04-03 2001-04-17 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
WO2000054803A2 (en) 1999-03-16 2000-09-21 Panacea Pharmaceuticals, Llc Immunostimulatory nucleic acids and antigens
AU1921601A (en) 1999-11-19 2001-05-30 Alabama A & M University Down-regulation and silencing of allergen genes in transgenic peanut seeds
DK1219300T3 (da) * 2000-12-28 2007-03-05 Biomay Prod & Handel Behandling af allergi

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARCHIVES OF BIOCHEMISTRY & BIOPHSICS 342,PP244-253 (1997) *

Also Published As

Publication number Publication date
WO1999038978A1 (en) 1999-08-05
CA2319437C (en) 2009-06-16
AU2350599A (en) 1999-08-16
ATE430199T1 (de) 2009-05-15
CA2319437A1 (en) 1999-08-05
EP1051494A1 (en) 2000-11-15
JP2002501748A (ja) 2002-01-22
US7485708B2 (en) 2009-02-03
US20030049237A1 (en) 2003-03-13
DE69940805D1 (de) 2009-06-10
EP1051494B1 (en) 2009-04-29

Similar Documents

Publication Publication Date Title
CA2319437C (en) Methods and reagents for decreasing allergic reactions
Vrtala et al. cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl p V allergen.
KR101699554B1 (ko) 백신용 펩티드
EP1373510B1 (en) Mutant allergens
Tscheppe et al. Recombinant allergens in structural biology, diagnosis, and immunotherapy
Valenta et al. Recombinant allergen molecules: tools to study effector cell activation
US20120283421A1 (en) Methods and reagents for decreasing clinical reaction to allergy
US6486311B1 (en) Peanut allergens and methods
Twardosz et al. Molecular characterization, expression inescherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4
JP6646480B2 (ja) アレルゲンエキスを製造するための方法
WO2001040264A2 (en) Peptide antigens
Platts-Mills et al. Future directions for allergen immunotherapy
WO2000052154A2 (en) Methods and reagents for decreasing clinical reaction to allergy
US7879977B2 (en) Methods and reagents for decreasing clinical reaction to allergy
WO2002074250A2 (en) Methods and reagents for decreasing clinical reaction to allergy
US20110052639A1 (en) Allergen mutants
JP2002512253A (ja) 新規なダーマトファゴイデス属（ｄｅｒｍａｔｏｐｈａｇｏｉｄｅｓ）核酸分子、タンパク質、およびそれらの使用方法
Singh et al. Hypoallergenic derivatives of major grass pollen allergens for allergy vaccination
AT402505B (de) Rekombinantes 60 kda pflanzliches panallergen (kofaktor-unabhängige phosphoglyceratmutase; e.c. 5.4.2.1.)
NZ246806A (en) Allergenic proteins and peptides from japanese cedar pollen, recombinant production and compositions
RU2285042C2 (ru) Новые мутантные аллергены
US20030175312A1 (en) Novel mutant allergens
EP1899367A1 (en) Mutant allergen(s)
Astwood et al. Cloning and expression pattern of Hor v 9, the group 9 pollen isoallergen from barley
MX2011009862A (es) Oligopeptidos sinteticos diseñados a partir de cisteinproteasas de acaros y metodos para la produccion de anticuerpos policlonales igy para la deteccion de acaros intradomiciliarios.

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: UNIVERSITY OF ARKANSAS, MT. SINAI SCHOOL OF MEDICI

Free format text: FORMER NAME: UNIVERSITY OF ARKANSAS, MT. SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK, HOWARD SOSIN

FGA Letters patent sealed or granted (standard patent)
PC1 Assignment before grant (sect. 113)

Owner name: UNIVERSITY OF ARKANSAS, PANACEA PHARMACEUTICALS, L

Free format text: THE FORMER OWNER WAS: UNIVERSITY OF ARKANSAS, MT. SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY, HOWARD SOSIN

PC Assignment registered

Owner name: UNIVERSITY OF ARKANSAS, SEER PHARMACEUTICALS, LLC,

Free format text: FORMER OWNER WAS: UNIVERSITY OF ARKANSAS, PANACEA PHARMACEUTICALS, LLC, MT. SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY